发文分析
近年国家/地区发文量统计
| 国家/地区 | 数量 |
|---|---|
| Italy | 131 |
| Spain | 91 |
| USA | 78 |
| GERMANY (FED REP GER) | 75 |
| England | 67 |
| France | 63 |
| Switzerland | 60 |
| Belgium | 58 |
| Austria | 50 |
| Japan | 38 |
近年机构发文量统计
| 机构 | 数量 |
|---|---|
| UNICANCER | 39 |
| MEDICAL UNIVERSITY OF VIENNA | 37 |
| FONDAZIONE IRCCS ISTITUTO NAZIONALE TUMORI MIL... | 36 |
| UNIVERSITY OF LONDON | 31 |
| INSTITUT JULES BORDET | 29 |
| UNIVERSITY OF VALENCIA | 28 |
| CIBER - CENTRO DE INVESTIGACION BIOMEDICA EN R... | 26 |
| NATIONAL CANCER CENTER - JAPAN | 26 |
| ROYAL MARSDEN NHS FOUNDATION TRUST | 26 |
| HOSPITAL UNIVERSITARI VALL D'HEBRON | 25 |
近年文章引用他刊数据
| 文章名称 | 引用次数 |
|---|---|
| Implementing TMB measurement in clinical practice: consi... | 47 |
| Immune checkpoint inhibition-related colitis: symptoms, ... | 43 |
| Modulation of peripheral blood immune cells by early use... | 32 |
| Multidisciplinary molecular tumour board: a tool to impr... | 24 |
| Global cancer control: responding to the growing burden,... | 24 |
| How shall we treat early triple-negative breast cancer (... | 23 |
| How we treat patients with lung cancer during the SARS-C... | 22 |
| Tolerability of BRAF/MEK inhibitor combinations: adverse... | 22 |
| New emerging targets in cancer immunotherapy: the role o... | 21 |
| How we treat glioblastoma | 21 |
近年被他刊引用数据
| 期刊名称 | 引用次数 |
|---|---|
| ESMO OPEN | 129 |
| CANCERS | 45 |
| INT J MOL SCI | 21 |
| FUTURE ONCOL | 15 |
| ANN ONCOL | 14 |
| BMC CANCER | 14 |
| CANCER MANAG RES | 14 |
| CRIT REV ONCOL HEMAT | 14 |
| FRONT ONCOL | 14 |
| ONCOLOGIST | 13 |